http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108467435-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0c762705b6c9556983a0c5e3ad905f8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate | 2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a48de138732a3b4420baa55618e9b2e |
| publicationDate | 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108467435-A |
| titleOfInvention | A kind of preparation method and application with depressor muscle acid anhydride and/or the yew amylose for improving endogenous creatinine clearance rate effect |
| abstract | The preparation method and application with depressor muscle acid anhydride, the yew amylose for improving endogenous creatinine clearance rate effect that the invention discloses a kind of, the preparation method of specific yew amylose include the following steps：A it) pre-processes；B) water extract-alcohol precipitation；C it) washs；D) deproteinized；E it) dialyses；F it) is freeze-dried.And application of the yew amylose being prepared using this method in depressor muscle acid anhydride and/or in terms of improving endogenous creatinine clearance rate is disclosed, and discloses the depressor muscle acid anhydride being prepared using the yew amylose that this method is prepared and/or improves the medicament of endogenous creatinine clearance rate.It is at low cost that the present invention extracts yew amylose, recovery rate and purity are high, obtained yew amylose has effects that depressor muscle acid anhydride, improves endogenous creatinine clearance rate, can prepare the drug that serum creatinine caused by for treating a variety of causes increases, endogenous creatinine clearance rate reduces, such as：The drug for treating chronic kidney disease, chronic renal failure etc. is conducive to restore renal function. |
| priorityDate | 2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.